Suvoda Introduces eConsent Advancements to Increase Patient Comprehension, Reduce Site Burden, and Improve Overall Experience
07.08.2025 - 18:05:28Suvoda eConsent offers a simplified approach to digitizing the consent management process. Purpose-built on the Suvoda Platform and seamlessly integrated with Suvoda IRT and eCOA, Suvoda eConsent gives sponsors, CROs, and sites improved visibility and automated control of consent throughout the life of a trial. It provides peace of mind that patient data is secure, compliant, and available at the moment of signature while supporting existing site processes. Learn more about features and benefits of Suvoda eConsent:
https://www.suvoda.com/products/econsent
About Suvoda
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company's Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,400 trials across 85 countries. To learn more, visit?suvoda.com. Follow Suvoda on?LinkedIn?and?X.
Contact:
Deb Massa
Suvoda
dmassa@suvoda.com
610.241.2170
Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/suvoda-introduces-econsent-advancements-to-increase-patient-comprehension-reduce-site-burden-and-improve-overall-experience-302090695.html
